The 55-second answer
GLP-1 medications don’t directly target sex hormones—but change cycles indirectly through three pathways: rapid weight loss shifts estrogen, caloric reduction stresses the hypothalamic-pituitary-ovarian axis, and improved insulin sensitivity changes ovarian hormone signaling. For perimenopausal women, these shifts land on an already-changing cycle.
Know your thyroid status—critical baseline before starting metabolic medications. If you’re also managing sleep disruption or perimenopause weight changes, GLP-1 protocol requires intentional support.
The three pathways
1. Fat tissue is an endocrine organ. Losing significant body fat quickly removes part of estrogen production.
2. The hypothalamus reads caloric deficit as stress. Your cycle is run by the hypothalamic-pituitary-ovarian axis. GLP-1s reduce intake 30–50%.
3. Insulin sensitivity and ovaries are wired together. Improved insulin sensitivity changes ovarian androgen production and follicle signaling.
Protecting your cycle on GLP-1
Protein: 30–40g per meal. Resistance training: 2–3x/week. Slower weight loss: 0.5–1 lb/week is gentler. Micronutrients: Iron, magnesium, vitamin D, B vitamins. Track your cycle.